Katherine Davis Net Worth

The estimated Net Worth of Katherine Lyon Davis is at least $122 Mille dollars as of 24 June 2021. Ms. Davis owns over 16,314 units of Chembio Diagnostics stock worth over $48,970 and over the last 17 years she sold CEMI stock worth over $0. In addition, she makes $73,500 as Independent Director at Chembio Diagnostics.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Davis CEMI stock SEC Form 4 insiders trading

Katherine has made over 5 trades of the Chembio Diagnostics stock since 2010, according to the Form 4 filled with the SEC. Most recently she exercised 16,314 units of CEMI stock worth $7,504 on 24 June 2021.

The largest trade she's ever made was exercising 46,875 units of Chembio Diagnostics stock on 6 May 2019 worth over $163,125. On average, Katherine trades about 10,060 units every 271 days since 2007. As of 24 June 2021 she still owns at least 106,457 units of Chembio Diagnostics stock.

You can see the complete history of Ms. Davis stock trades at the bottom of the page.

Katherine Davis biography

Katherine Lyon Davis serves as Independent Director of the Company. She was Chair of the Board from March 2014 until April 2020. Owner of Davis Design Group LLC, a provider of analytical and visual tools for public policy design, since 2007 • Chief Executive Officer of Global Access Point, a start-up company with products for data transport, data processing, and data storage network and hub facilities, from 2005 to 2006 • Lieutenant Governor of the State of Indiana from 2003 to 2005 • Controller of the City of Indianapolis from 2000 to 2003 • Financial Advisor to the Mayor of Indianapolis since January 2016. she holds Masters in Business Administration degree from Harvard Business School and Bachelor of Science degree in mechanical engineering from the Massachusetts Institute of Technology.

What is the salary of Katherine Davis?

As the Independent Director of Chembio Diagnostics, the total compensation of Katherine Davis at Chembio Diagnostics is $73,500. There are 4 executives at Chembio Diagnostics getting paid more, with Javan Esfandiari having the highest compensation of $557,521.

How old is Katherine Davis?

Katherine Davis is 63, she's been the Independent Director of Chembio Diagnostics since 2020. There are 2 older and 5 younger executives at Chembio Diagnostics. The oldest executive at Chembio Diagnostics Inc. is Mary Polan, 76, who is the Independent Director.

What's Katherine Davis's mailing address?

Katherine's mailing address filed with the SEC is C/O CHEMBIO DIAGNOSTICS, INC., 3661 HORSEBLOCK ROAD, MEDFORD, NY, 11763.

Insiders trading at Chembio Diagnostics

Over the last 20 years, insiders at Chembio Diagnostics have traded over $909,824 worth of Chembio Diagnostics stock and bought 3,754,893 units worth $1,696,058 . The most active insiders traders include Credit Advisors, Llcpercept..., Lawrence A. Siebert e Richard Eberly. On average, Chembio Diagnostics executives and independent directors trade stock every 90 days with the average trade being worth of $36,203. The most recent stock trade was executed by Credit Advisors, Llcpercept... on 21 April 2023, trading 243,448 units of CEMI stock currently worth $109,552.

What does Chembio Diagnostics do?

Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.

Complete history of Ms. Davis stock trades at Chembio Diagnostics

Chembio Diagnostics executives and stock owners

Chembio Diagnostics executives and other stock owners filed with the SEC include:

• Javan Esfandiari,
  Exec. VP and Chief Science & Technology Officer
• Richard L. Eberly,
  Pres, CEO & Director
• Javan Esfandiari,
  Executive Vice President, Chief Scientific And Technology Officer
• Neil Goldman,
  Chief Financial Officer, Executive Vice President
• Katherine Davis,
  Independent Director
• John Potthoff,
  Independent Director
• Gail Page,
  Executive Chairman of the Board
• Mary Polan,
  Independent Director
• Lynn Lewis,
  Investor Relations Contact Officer
• Chuck Caso,
  Vice President of Sales and Marketing for North America
• Richard Eberly,
  President, Chief Executive Officer, Director
• Stella Rivera,
  VP of HR
• Atif Rizvi,
  VP of Fin.
• Dr. Konstantin Lyashchenko,
  Research Director of Chembio Diagnostic Systems Inc
• Charles Caso,
  VP of Sales & Marketing
• Paul J. Angelico,
  VP of Global Operations
• Peter Kissinger,
  Director
• Richard J Larkin,
  Chief Financial Officer
• Barbara A De Buono,
  Director
• John J Iii Sperzel,
  CEO
• Robert L Aromando,
  Sr VP, Commercial Operations
• Alan Carus,
  Director
• Lawrence A. Siebert,
  President
• Leslie Teso Lichtman,
  
• Norman H Pessin Brian L. Pe...,
  
• Gary Meller,
  Director
• Sharon W Klugewicz,
  Chief Operating Officer
• David Gyorke,
  See Remarks
• Robert Passas,
  See Remarks
• Avi Pelossof,
  Vice President
• Gerald A Eppner,
  Director
• James D Merselis,
  Director
• Capital Master Llc Crestvie...,
  
• David Acheson,
  
• Credit Advisors, Llcpercept...,
  
• David William Bespalko,
  
• Lawrence J. Steenvoorden,
  See remarks
• Charles Caso,
  See Remarks
• Paul Angelico,
  See remarks